Home
Conditions
Neoplastic Cells, Circulating

Clinical trial condition

Neoplastic Cells, Circulating

Explore clinical trials studying Neoplastic Cells, Circulating. Study availability and eligibility vary by location and protocol.

133 public trials 40 recruiting studies

Refine in advanced search Browse all conditions

Neoplastic Cells, Circulating trial results

Completed

Mesenchymal CTC Ratio Dynamics Predicts Response and Survival in Pancreatic Ductal Adenocarcinoma With Neoadjuvant/Conversion Therapy

NCT07329920

Conditions: Circulating Tumor Cells (CTCs), Neoadjuvant Therapy, Neoplasm Metastasis, +6 more
Locations: Department of Hepatobiliary and Pancreatic Surgery, First Affiliated Hospital of Naval Medical UniversityUniversity Shanghai, Shanghai Municipality, China

View Trial Details

Completed

A Clinical Trial to Compare Efficacy and Tolerability of Atorvastatin in Addition to Endocrine Treatment With Focus on Mechanisms of Resistance to Endocrine Treatment (Fulvestrant/Aromatase Inhibitors) in Patients With Advanced Breast Cancer

NCT02958852

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +9 more
Locations: Lund University Hospital, Department of Oncology Lund, Sweden

View Trial Details

Completed

Genomic Markers for Measuring Breast Cancer Response to Neoadjuvant Chemotherapy

NCT03709134

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +10 more
Locations: Sunnybrook Health Sciences Centre Toronto, Ontario, Canada

View Trial Details

Completed

Analysis of Circulating Tumor Markers in the Blood (ALCINA)

NCT02866149

Conditions: Cancer, Neoplasm Metastasis, Neoplasms, +4 more
Locations: Centre Georges François Leclerc Dijon, France

Institut du Cancer de Montpellier Montpellier, France

Institut Curie (Paris hospital) Paris, France

Institut Mutualiste Montsouris Paris, France

View Trial Details

Completed

Primary Operation in SYnchronous meTastasized InVasivE Breast Cancer

NCT01015625

Conditions: Breast Diseases, Breast Neoplasms, Circulating Tumor Cells, +10 more
Locations: Hospital Guessing Guessing, Burgenland, Austria

Hospital Oberpullendorf Oberpullendorf, Burgenland, Austria

Ordination Dr. Wette Saint Veit A. D. Glan, Carinthia, Austria

Gynaegological Medical University Graz Graz, Styria, Austria

View all 14 locations

View Trial Details

Completed

DETECT III - A Multicenter, Phase III Study to Compare Standard Therapy +/- Lapatinib in HER2-ve MBC-Patients With HER2+ve CTCs

NCT01619111

Conditions: Breast Diseases, Breast Neoplasms, HER2-negative Metastatic Breast Cancer, +10 more
Locations: University Hospital Ulm Ulm, Baden-Wurttemberg, Germany

View Trial Details

Completed

DETECT IV - A Study in Patients With HER2-negative Metastatic Breast Cancer and Persisting HER2-negative Circulating Tumor Cells (CTCs).

NCT02035813

Conditions: Breast Diseases, Breast Neoplasms, HER2-negative Circulating Tumor Cells, +11 more
Locations: University Hospital Ulm -Department of Gynecology Ulm, Baden-Wurttemberg, Germany

View Trial Details

Completed

Role of CTC´s Spread During Pancreaticoduodenectomy in Patients With Pancreatic and Periampullary Tumors

NCT03340844

Conditions: Circulating Tumor Cells, Digestive System Diseases, Digestive System Neoplasms, +14 more
Locations: Hospital Universitario Virgen del Rocío Seville, Spain

View Trial Details

Completed

Circulating Tumor DNA and Follow-up of BRCA1 Mutation Carriers (CirCa 01)

NCT02608346

Conditions: Neoplasm Metastasis, Neoplasms, Neoplastic Cells, Circulating, +4 more
Locations: Centre Léon Bérard Lyon, France

Institut Curie Paris, France

Hôpital René Huguenin - Institut Curie Saint-Cloud, France

Institut Gustave ROUSSY Villejuif, France

View Trial Details

Completed

Digoxin Induced Dissolution of CTC Clusters

NCT03928210

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +10 more
Locations: Kantonspital Baselland (KSBL) Liestal, Basel-Landschaft, Switzerland

Breast Cancer Center, University Hospital Basel Basel, Switzerland

University Hospital Zurich (USZ) Zurich, Switzerland

View Trial Details

Neoplastic Cells, Circulating

Neoplastic Cells, Circulating trial results

Related conditions